Thursday 08 April 2021
Thursday 08 April 2021
14:45 - 15:00: Welcome:
15:00 - 15:30
Cutting edge session 1 - Molecular mechanisms behind women's biological clock
15:00 - 15:30: Cutting edge session 1 - Molecular mechanisms behind women's biological clock:
Nicholas Macklon, Denmark
15:00 - 15:20
Molecular mechanisms behind women's biological clock
15:30 - 16:30
Debate session 1 - Treatment of recurrent implantation failure
15:30 - 16:30: Debate session 1 - Treatment of recurrent implantation failure:
Nicholas Macklon, Denmark
15:30 - 15:45
Treatment of recurrent implantation failure - Pro
15:45 - 16:00
Treatment of recurrent implantation failure - Con
16:30 - 16:50
Plenary lecture 1 - No way back: The end of donor anonymity
16:30 - 16:50: Plenary lecture 1 - No way back: The end of donor anonymity:
Nicholas Macklon, Denmark
16:30 - 16:50
No way back: The end of donor anonymity
Joyce Harper, United Kingdom
16:50 - 17:00: Break:
17:00 - 18:00
Back-to-back session 1 - Social egg freezing: Exploitation or emancipation
17:00 - 18:00: Back-to-back session 1 - Social egg freezing: Exploitation or emancipation:
17:00 - 17:20
Social egg freezing: Exploitation or emancipation
17:20 - 17:40
Social egg freezing: Exploitation or emancipation
18:00 - 18:20
Plenary lecture 2 - Spermatogenesis in vitro
18:00 - 18:20: Plenary lecture 2 - Spermatogenesis in vitro:
18:00 - 18:20
Gene therapies for male infertility
18:20 - 19:20
Debate session 2 - To pill or not to pill: Scheduling improves IVF outcome
18:20 - 19:20: Debate session 2 - To pill or not to pill: Scheduling improves IVF outcome:
18:20 - 18:35
To pill or not to pill: Scheduling improves IVF outcome - Pro
Juan A. Garcia-Velasco, Spain
18:35 - 18:50
To pill or not to pill: Scheduling improves IVF outcome - Con
Juan A. Garcia-Velasco, Spain
14:30 - 15:00
Cutting edge session 2 - The future IVF laboratory
Friday 09 April 2021
14:30 - 15:00: Cutting edge session 2 - The future IVF laboratory:
14:30 - 14:50
The future IVF laboratory
15:00 - 16:00
Debate session 3 - Fibroids must be treated prior to IVF
15:00 - 16:00: Debate session 3 - Fibroids must be treated prior to IVF:
15:00 - 15:15
Fibroids must be treated prior to IVF - Con
Michelle Nisolle, Belgium
15:15 - 15:30
Fibroids must be treated prior to IVF - Pro
Michelle Nisolle, Belgium
16:00 - 16:20
Plenary lecture 3 - Beyond the Barker hypothesis
16:00 - 16:20: Plenary lecture 3 - Beyond the Barker hypothesis:
16:00 - 16:20
Beyond the Barker hypothesis
16:20 - 16:30: Break:
16:30 - 17:30
Back-to-back session 2 - Strategy of dual stimulation
16:30 - 17:30: Back-to-back session 2 - Strategy of dual stimulation:
Richard Anderson, United Kingdom
Michael A. Thomas, U.S.A.
16:30 - 16:50
Strategy of dual stimulation
Filippo Maria Ubaldi, Italy
16:50 - 17:10
Strategy of dual stimulation
17:30 - 17:50
Plenary lecture 4 - Clinical application of oocyte in vitro maturation
17:30 - 17:50: Plenary lecture 4 - Clinical application of oocyte in vitro maturation:
Richard Anderson, United Kingdom
Michael A. Thomas, U.S.A.
17:30 - 17:50
Clinical application of oocyte in vitro maturation
17:50 - 18:50
Back-to-back session 3 - Update on müllerian duct anomalies
17:50 - 18:50: Back-to-back session 3 - Update on müllerian duct anomalies:
Richard Anderson, United Kingdom
Michael A. Thomas, U.S.A.
17:50 - 18:10
Update on müllerian duct anomalies: Understanding causal mechanisms
18:10 - 18:30
Update on müllerian duct anomalies: Modern surgical approaches
18:50 - 19:50
Debate session 4 - PGT-A for everyone
18:50 - 19:50: Debate session 4 - PGT-A for everyone:
Richard Anderson, United Kingdom
Michael A. Thomas, U.S.A.
18:50 - 19:05
PGT-A for everyone - Pro
Richard J. Paulson, U.S.A.
19:05 - 19:20
PGT-A for everyone - Con
Richard J. Paulson, U.S.A.
15:00 - 15:30
Cutting edge session 3 - Synthetic human entities with embryo-like features
Saturday 10 April 2021
15:00 - 15:30: Cutting edge session 3 - Synthetic human entities with embryo-like features:
15:00 - 15:20
Synthetic human entities with embryo-like features
Susana M. Chuva de Sousa Lopes, The Netherlands
15:30 - 16:30
Debate session 5 - Thrombophilia is a relevant factor for ART outcome
15:30 - 16:30: Debate session 5 - Thrombophilia is a relevant factor for ART outcome:
15:30 - 15:45
Inherited and Acquired Thrombophilias: A Relevant Factor for ART outcome?- Pro
William H. Kutteh, U.S.A.
15:45 - 16:00
Inherited and Acquired Thrombophilias: A Relevant Factor for ART outcome? - Con
Beverley Hunt, United Kingdom
William H. Kutteh, U.S.A.
Beverley Hunt, United Kingdom
16:30 - 16:50
Plenary lecture 5 - Biological sensors of in-utero monitoring
16:30 - 16:50: Plenary lecture 5 - Biological sensors of in-utero monitoring:
16:30 - 16:50
Biological sensors of in-utero monitoring
Ying Cheong, United Kingdom
16:50 - 17:00: Break:
17:00 - 18:00
Back-to-back session 4 - Controversies in the management of severe male factor
17:00 - 18:00: Back-to-back session 4 - Controversies in the management of severe male factor:
17:00 - 17:20
Controversies in the management of severe male factor
Adam Watkins, United Kingdom
17:20 - 17:40
Controversies in the management of severe male factor
Peter N. Schlegel, U.S.A.
18:00 - 18:20
Plenary lecture 6 - Obesity and reproductive function
18:00 - 18:20: Plenary lecture 6 - Obesity and reproductive function:
18:00 - 18:20
Obesity and reproductive function
Robert John Norman, Australia
18:20 - 19:20
Debate session 6 - Cleavage stage transfer should be abandoned
18:20 - 19:20: Debate session 6 - Cleavage stage transfer should be abandoned:
18:20 - 18:35
Cleavage stage transfer should be abandoned - Pro
18:35 - 18:50
Cleavage stage transfer should be abandoned - Con
Catherine Racowsky, France
Catherine Racowsky, France